My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 147

    1.

    A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy.

    Facchini FS, Saylor KL.

    Diabetes. 2003 May;52(5):1204-9.PMID: 12716753 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis.

    Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH.

    Ann Intern Med. 1996 Apr 1;124(7):627-32.PMID: 8607590 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.

    Meloni C, Tatangelo P, Cipriani S, Rossi V, Suraci C, Tozzo C, Rossini B, Cecilia A, Di Franco D, Straccialano E, Casciani CU.

    J Ren Nutr. 2004 Oct;14(4):208-13.PMID: 15483780 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of diabetic nephropathy with angiotensin II receptor antagonist.

    Lewis EJ, Lewis JB.

    Clin Exp Nephrol. 2003 Mar;7(1):1-8. Review.PMID: 14586737 [PubMed - indexed for MEDLINE]Related articles

    5.

    Factors affecting progression of renal failure in patients with type 2 diabetes.

    Ueda H, Ishimura E, Shoji T, Emoto M, Morioka T, Matsumoto N, Fukumoto S, Miki T, Inaba M, Nishizawa Y.

    Diabetes Care. 2003 May;26(5):1530-4.PMID: 12716817 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Diabetic nephropathy: how effective is treatment in clinical practice?

    Joss N, Paterson KR, Deighan CJ, Simpson K, Boulton-Jones JM.

    QJM. 2002 Jan;95(1):41-9.PMID: 11834772 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy.

    Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH.

    Kidney Int. 2002 Jul;62(1):220-8.PMID: 12081581 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Severe dietary protein restriction in overt diabetic nephropathy: benefits or risks?

    Meloni C, Morosetti M, Suraci C, Pennafina MG, Tozzo C, Taccone-Gallucci M, Casciani CU.

    J Ren Nutr. 2002 Apr;12(2):96-101.PMID: 11953922 [PubMed - indexed for MEDLINE]Related articles

    9.

    Protein restriction for diabetic renal disease.

    Robertson L, Waugh N, Robertson A.

    Cochrane Database Syst Rev. 2007 Oct 17;(4):CD002181. Review.PMID: 17943769 [PubMed - indexed for MEDLINE]Related articles

    10.

    [The role of the diet as a risk factor for the development and progression of diabetic nephropathy]

    Mello VD, Azevedo MJ, Zelmanovitz T, Gross JL.

    Arq Bras Endocrinol Metabol. 2005 Aug;49(4):485-94. Epub 2005 Oct 19. Review. Portuguese. PMID: 16358075 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Protein restriction for diabetic renal disease.

    Waugh NR, Robertson AM.

    Cochrane Database Syst Rev. 2000;(2):CD002181. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD002181. PMID: 10796869 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.

    Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM; RENAAL Study Group.

    Arch Intern Med. 2003 Jul 14;163(13):1555-65.PMID: 12860578 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.

    Leung WY, So WY, Tong PC, Chan NN, Chan JC.

    Am J Med. 2005 Dec;118(12):1414.PMID: 16378791 [PubMed - indexed for MEDLINE]Related articles

    14.

    Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.

    Buraczynska K, Koziol-Montewka M, Majdan M, Tokarz A, Ksiazek A.

    Ren Fail. 2004 Nov;26(6):633-9.PMID: 15600254 [PubMed - indexed for MEDLINE]Related articles

    15.

    Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.

    Ruilope LM, Segura J.

    Clin Ther. 2003 Dec;25(12):3044-64. Review.PMID: 14749145 [PubMed - indexed for MEDLINE]Related articles

    16.

    A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy.

    Dussol B, Iovanna C, Raccah D, Darmon P, Morange S, Vague P, Vialettes B, Oliver C, Loundoun A, Berland Y.

    J Ren Nutr. 2005 Oct;15(4):398-406.PMID: 16198932 [PubMed - indexed for MEDLINE]Related articles

    17.

    Progression of nephropathy in type 2 diabetic patients.

    Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.

    Kidney Int. 2004 Oct;66(4):1596-605.PMID: 15458456 [PubMed - indexed for MEDLINE]Related articles

    18.

    The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.

    Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM.

    Am J Kidney Dis. 2005 Nov;46(5):863-70.PMID: 16253726 [PubMed - indexed for MEDLINE]Related articles

    19.

    Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

    de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM.

    Kidney Int. 2004 Jun;65(6):2309-20.PMID: 15149345 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prevention and treatment of diabetic nephropathy: the program for irbesartan mortality and morbidity evaluation.

    Ravera M, Ratto E, Vettoretti S, Parodi D, Deferrari G.

    J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S48-52. Review.PMID: 15938034 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity